Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Long-Term Investments (2022 - 2023)

Envoy Medical's Long-Term Investments history spans 2 years, with the latest figure at $44.6 million for Q2 2023.

  • Quarterly results put Long-Term Investments at $44.6 million for Q2 2023, down 89.51% from a year ago — trailing twelve months through Jun 2023 was $44.6 million (down 89.51% YoY), and the annual figure for FY2022 was $353731.0, changed.
  • Long-Term Investments for Q2 2023 was $44.6 million at Envoy Medical, up from $44.4 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $427.1 million in Q3 2022 to a low of $353731.0 in Q4 2022.